Fosun Pharma Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 40,603

Employees

  • Stock Symbol
  • 600196

Stock Symbol

  • Investments
  • 114

  • Share Price
  • $3.11
  • (As of Thursday Closing)

Fosun Pharma General Information

Description

Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 1289 Yishan Road
  • Building A, Fosun Technology Park
  • Shanghai, 200233
  • China
+86 021
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHG
Corporate Office
  • Number 1289 Yishan Road
  • Building A, Fosun Technology Park
  • Shanghai, 200233
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fosun Pharma Stock Performance

As of 19-Nov-2026, Fosun Pharma’s stock price is $3.11. Its current market cap is $7.64B with 2.67B shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.11 $3.12 $3.06 - $4.12 $7.64B 2.67B 19.9M $0.19

Fosun Pharma Financials Summary

As of 30-Sep-2026, Fosun Pharma has a trailing 12-month revenue of $6.2B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 14,776,768 14,552,363 12,468,325 12,554,414
Revenue 6,199,504 5,793,319 5,723,284 5,851,624
EBITDA 886,114 1,333,533 1,146,899 1,016,404
Net Income 509,926 468,699 386,022 337,287
Total Assets 18,912,949 17,158,656 16,090,268 16,007,336
Total Debt 6,143,216 5,444,315 4,953,097 4,952,962
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Fosun Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fosun Pharma‘s full profile, request access.

Request a free trial

Fosun Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, sale of pharmaceutical products
Drug Delivery
Shanghai, China
40,603 As of 2025

Mumbai, India
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fosun Pharma Competitors (3)

One of Fosun Pharma’s 3 competitors is Cipla, a Corporation company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India
Roche Corporation Basel, Switzerland
Dr. Reddy's Corporation Hyderabad, India
You’re viewing 3 of 3 competitors. Get the full list »

Fosun Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fosun Pharma Investments & Acquisitions (114)

Fosun Pharma’s most recent deal was a Later Stage VC with Fosun Adgenvax for . The deal was made on 24-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Fosun Adgenvax 24-Jun-2026 Later Stage VC Pharmaceuticals
Hepa Thera 26-May-2026 Early Stage VC Drug Discovery
AriBio 13-May-2026 Corporate Drug Discovery
Aixindawei Pharmaceutical 06-May-2026 Later Stage VC Drug Discovery
Omix Science 24-Apr-2026 Early Stage VC Decision/Risk Analysis
You’re viewing 5 of 114 investments and acquisitions. Get the full list »

Fosun Pharma ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

29.34 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Fosun Pharma’s complete esg history, request access »

Fosun Pharma Exits (28)

Fosun Pharma’s most recent exit was on 10-Jan-2022 from InSilico Medicine Cayman. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
InSilico Medicine Cayman 10-Jan-2022 Completed
  • 2 buyers
Gyroscope 26-Mar-2021 Completed
  • 6 buyers
MitrAssist 02-Dec-2020 Completed
  • 7 buyers
Hinova Pharmaceuticals 24-Aug-2020 Completed
  • 11 buyers
BioNTech 17-Mar-2020 PIPE Completed
You’re viewing 5 of 28 exits. Get the full list »

Fosun Pharma Affiliates

Subsidiaries (21)

Name Industry Location Year Founded
XingMeiShengWu Tianjin, China 2020
Fosun Health Capital Shanghai, China 2019
Fosun Aitrox Shanghai, China 2017
Hermed Capital Shanghai, China 2014
Fosun Adgenvax Chengdu, China 2012
You’re viewing 5 of 21 affiliates. Get the full list.  »

Fosun Pharma FAQs

  • When was Fosun Pharma founded?

    Fosun Pharma was founded in 1994.

  • Where is Fosun Pharma headquartered?

    Fosun Pharma is headquartered in Shanghai, China.

  • What is the size of Fosun Pharma?

    Fosun Pharma has 40,603 total employees.

  • What industry is Fosun Pharma in?

    Fosun Pharma’s primary industry is Drug Delivery.

  • Is Fosun Pharma a private or public company?

    Fosun Pharma is a Public company.

  • What is Fosun Pharma’s stock symbol?

    The ticker symbol for Fosun Pharma is 600196.

  • What is the current stock price of Fosun Pharma?

    As of 19-Nov-2026 the stock price of Fosun Pharma is $3.11.

  • What is the current market cap of Fosun Pharma?

    The current market capitalization of Fosun Pharma is $7.64B.

  • What is Fosun Pharma’s current revenue?

    The trailing twelve month revenue for Fosun Pharma is $6.2B.

  • Who are Fosun Pharma’s competitors?

    Cipla, Roche, and Dr. Reddy's are competitors of Fosun Pharma.

  • What is Fosun Pharma’s annual earnings per share (EPS)?

    Fosun Pharma’s EPS for 12 months was $0.19.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process